Intens Care Med:40万ICU患者的发现:高个比矮个命长

2018-12-29 卢芳 中国循环杂志

也许一个人的身高也是一种潜在的生命信息,比如曾有研究显示个儿高的人癌症风险高。

也许一个人的身高也是一种潜在的生命信息,比如曾有研究显示个儿高的人癌症风险高。

不过,近日一项纳入40万重症监护患者的研究则显示,个儿最矮的(1.37米)比个儿最高的(1.98米)在治疗中更可能死亡。
 
研究显示,在高个儿患者组中,院内死亡风险在男性为21%,在女性为17%;而矮个儿组中,男性为29%,女性为24%。
 
而且,即使考虑了其他因素,身高还是与死亡率间存在较强相关性。此外,身高还是预测患者出院的因素。
 
不过,研究者指出,这只是种发现的现象,而非因果关系。
 
为什么矮个儿会“倒霉”?
 
研究者表示,治疗中所用的设施和导管通常是一个尺寸,但对所有高矮胖瘦之人并非普遍适用。这或许是其中原因之一。
 
研究者指出,在治疗患者时,身高体重都是值得考虑的问题。
 
该研究共纳入了2009~2015年英国210个ICU的数据,其中包括233000位男性和184000位女性。

原始出处:Emily A. Vail, David A. Harrison, Hannah Wunsch. Relationship between height and outcomes among critically ill adults: a cohort study. Intens Care Med, Dec, 23, 2018.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2039005, encodeId=8332203900576, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 12 21:13:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595373, encodeId=050815953e355, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609442, encodeId=5d0d16094423a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356694, encodeId=8bd93566942e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Dec 29 21:16:19 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2039005, encodeId=8332203900576, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 12 21:13:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595373, encodeId=050815953e355, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609442, encodeId=5d0d16094423a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356694, encodeId=8bd93566942e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Dec 29 21:16:19 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2039005, encodeId=8332203900576, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 12 21:13:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595373, encodeId=050815953e355, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609442, encodeId=5d0d16094423a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356694, encodeId=8bd93566942e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Dec 29 21:16:19 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2039005, encodeId=8332203900576, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 12 21:13:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595373, encodeId=050815953e355, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609442, encodeId=5d0d16094423a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Dec 31 10:13:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356694, encodeId=8bd93566942e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Dec 29 21:16:19 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
    2018-12-29 医者仁心5538

    学习了

    0

相关资讯

NEJM:泮托拉唑治疗ICU消化道出血风险患者疗效

由此可见,ICU中有胃肠道出血风险的成年患者中,90天的死亡率和临床重要事件的数量中接受泮托拉唑和安慰剂治疗的患者中相似。

Intens Care Med:ICU幸存者心理疾病预测工具

由此可见,该研究开发了一种工具来预测ICU术后3个月内患者发生心理问题的风险。

Neurology:NMDAR脑炎患者1年预后预测评分

功能状态(NEOS)评分对NMDAR脑炎患者1年预后具有极高的预测价值

住院老人需急救ICU大门5分钟没打开,医院被判赔30万

老人因冠心病、心肌梗死住院治疗,三天后,老人病情恶化,需要送到ICU抢救,没想到此时ICU的门无法打开,家属称耽误了5分钟时间。老人经抢救无效去世,家属将医院起诉到法院,法院判决医院赔偿老人家属30万余元。2015年1月3日15时18分,林老太因病在金州一家医院住了院,医生为其做了多项检查,诊断老人为冠心病,急性高侧壁ST段抬高性心肌梗死。家属称,老人住院期间,院方仅用药物治疗,并没有告知老人所患

PLos One:使用便携式胸部X光检查的ICU患者增强气胸可视化

新型增强软件改善了气胸的检测;经验较少的阅片者中可以看到最大的改进。

ICU的血管扩张性休克:风险、误区和治疗选择

前言 循环衰竭在ICU中常见并且表现为心血管不稳定。休克被定义为低血压导致的器官灌注减少和细胞利用不足。即使术中短暂低血压也可导致肾脏和心肌损伤。术中导致末梢器官功能障碍的低血压程度被界定为平均动脉压(MAP)<65mmHg。在住ICU的危重患者中,和预后不良相关的MAP阈值尚不清楚,可能取决于基础血压和其他的患者特征。最近的拯救脓毒症运动指南界定这一阈值为MAP<65mmHg。危重患者的低